Tagged in: 苏州桑拿EF

The 5 Takeaways from the Coyotes introduction of

first_img The 5: Takeaways from the Coyotes’ introduction of Alex Meruelo Baltimore Ravens free safety Eric Weddle, left, celebrates with teammate Tony Jefferson after running back an interception for a touchdown. (AP Photo/Gail Burton, File) 47 Comments   Share   Top Stories Last season in Minnesota, he started only two games and missed 14 due to a knee injury.Players around the league also reacted to Bradford’s new deal. Former Cardinals defensive back Jerraud Powers quoted a tweet by reporter Adam Schefter about the deal with the following:Sam been getting paid since he got drafted #1 lol https://t.co/F2GSNuqKOT— Jerraud Powers (@JPowers25) March 13, 2018Pro Bowl safety Eric Weddle of the Baltimore Ravens took it a step further.So dumb. Bradford has been paid more for nothing than anyone in history of nfl— Eric Weddle (@weddlesbeard) March 13, 2018Bradford signed a massive six-year, $78 million contract with the Rams in 2010, the last year before the new collective bargaining agreement took hold in the NFL. In March of 2016, he inked a two-year, $36 million contract with the Philadelphia Eagles.And Wednesday, he’ll finalize his third contract, which means he would have earned $134 million over eight NFL seasons. So, the Arizona Cardinals got a quarterback.Free agent Sam Bradford reportedly agreed to a deal with the Cardinals on Tuesday that will pay him $20 million in 2018, $15 million of which is guaranteed.The signing generated plenty of reaction locally and nationally, mostly of the “Bradford is decent — when he’s healthy” variety.It’s a valid point.Related LinksRapid Reaction: Cardinals to sign quarterback Sam BradfordBradford has played in only 62.5 percent of regular season games since the St. Louis Rams made him the top overall choice in the 2010 draft. Former Cardinals kicker Phil Dawson retires Derrick Hall satisfied with D-backs’ buying and selling Grace expects Greinke trade to have emotional impactlast_img read more

Public Health Issues Climate Change Funding For Alzheimers Research

first_imgPublic Health Issues: Climate Change; Funding For Alzheimer’s Research This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. A medical expert calls for hospitals and health care officials to begin to plan for global warming problems, and The Wall Street Journal looks at new ways to finance research.Kaiser Health News: Health Care System Needs To Prepare For Global WarmingClimate change is happening, and with that will come more deaths from heat-related illness and disease, according to a report released Tuesday. “One of the most striking findings in our analysis is that increasing heat and humidity in some parts of the country could lead to outside conditions that are literally unbearable to humans, who must maintain a skin temperature below 95°F in order to effectively cool down and avoid fatal heat stroke,” the report’s authors wrote. … Dr. Al Sommer, the dean emeritus of the Bloomberg School of Public Health at Johns Hopkins University in Baltimore, was on the committee that oversaw the development of the report. He says that often overlooked in the current debate about greenhouse gases and climate change is the effect of global warming on individuals and hospitals” (Gillespie, 6/26).The Wall Street Journal: Should Alzheimer’s Bonds Be Issued To Fund Drug Development? The quest for a treatment that can combat Alzheimer’s remains frustrating and expensive, but Andrew Lo believes he may have a path forward. A finance professor who directs the Laboratory for Financial Engineering at the MIT Sloan School of Management, Lo thinks that a public-private partnership could solve some of the funding issues that have plagued drug discovery and development. The plan, which he recently discussed in a paper in Science Translational Medicine, is to create what the pharmaceutical world likes to call ‘lots of shots on goal.’ We spoke with Lo about his idea (Silverman, 6/25).Meanwhile, entrepreneurs express optimism about harnessing health data to create new patient tools -CQ Healthbeat:  Tech Companies, Congress Look to Health Data to Create New Patient ToolsSilicon Valley entrepreneur Anne Wojcicki had to halt sales of her company’s genetic tests for medical uses last year after the Food and Drug Administration voiced concerns over how the data would be used and its accuracy. That experience hasn’t soured Wojcicki’s outlook on the role that the government may play going forward in transforming a growing wealth of data into practical tools for improving the health of Americans. In fact, in a Tuesday interview, she was enthusiastic about the steps that officials within the Department of Health and Human Services are taking to make personal health information and broader health trends accessible (Young, 6/25). last_img read more